Insider · CIK 0001428524

Kessler Paul D.

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001428524

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2012-04-05	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−5,167 sh	$1.90	−$9,817.3	105,128
2011-05-16	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−7,500 sh	$5.53	−$41.4K	115,171
2011-05-16	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−4,876 sh	$5.48	−$26.7K	110,295
2011-04-05	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−8,596 sh	$5.76	−$49.5K	122,671
2011-04-01	VXRTVaxart, Inc.A Award	SVP Clinical, Med. & Reg.; CMO	AAward	+36K sh	—	—	131,267
2011-04-01	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	SVP Clinical, Med. & Reg.; CMO	AAward	+90K sh	—	—	90,000
2011-01-05	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−2,985 sh	$5.65	−$16.9K	95,267
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−300 sh	$5.68	−$1,704	112,952
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−50 sh	$5.68	−$284.25	112,902
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−850 sh	$5.69	−$4,836.5	112,052
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−1,000 sh	$5.70	−$5,695	111,052
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−3,205 sh	$5.70	−$18.3K	107,847
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−700 sh	$5.71	−$3,993.5	107,147
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−3,592 sh	$5.71	−$20.5K	103,555
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−100 sh	$5.71	−$571.5	103,455
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−1,900 sh	$5.72	−$10.9K	101,555
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−100 sh	$5.72	−$572.5	101,455
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−1,400 sh	$5.73	−$8,022	100,055
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−1,003 sh	$5.74	−$5,757.22	99,052
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−600 sh	$5.75	−$3,450	98,452
2010-05-17	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−200 sh	$5.76	−$1,152	98,252
2010-04-05	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−200 sh	$5.30	−$1,060	118,300
2010-04-05	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−928 sh	$5.31	−$4,927.68	117,372
2010-04-05	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−1,520 sh	$5.32	−$8,086.4	115,852
2010-04-05	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−700 sh	$5.34	−$3,738	115,152
2010-04-05	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−200 sh	$5.36	−$1,072	114,952
2010-04-05	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−500 sh	$5.37	−$2,685	114,452
2010-04-05	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−600 sh	$5.38	−$3,228	113,852
2010-04-05	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−600 sh	$5.39	−$3,234	113,252
2010-04-01	VXRTVaxart, Inc.A Award	SVP Clinical, Med. & Reg.; CMO	AAward	+36K sh	—	—	118,500
2010-04-01	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	SVP Clinical, Med. & Reg.; CMO	AAward	+90K sh	—	—	90,000
2010-03-15	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	SVP Clinical, Med. & Reg.; CMO	AAward	+1,000 sh	—	—	1,000
2009-11-23	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−602 sh	$5.00	−$3,010.903	82,500
2009-11-20	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−1,000 sh	$4.92	−$4,920	97,740
2009-11-20	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−2,000 sh	$4.91	−$9,820	95,740
2009-11-20	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−7,136 sh	$4.90	−$35K	88,604
2009-11-20	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−5,502 sh	$4.89	−$26.9K	83,102
2009-11-19	VXRTVaxart, Inc.S Sale	SVP Clinical, Med. & Reg.; CMO	SSale	−2,500 sh	$4.90	−$12.3K	98,740
2009-04-01	VXRTVaxart, Inc.A Award	SVP Clinical, Med. & Reg.; CMO	AAward	+30K sh	—	—	101,240
2009-04-01	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	SVP Clinical, Med. & Reg.; CMO	AAward	+90K sh	—	—	90,000
2008-04-01	VXRTVaxart, Inc.A Award	SVP Clinical, Med. & Reg.; CMO	AAward	+30K sh	—	—	71,240
2008-04-01	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	SVP Clinical, Med. & Reg.; CMO	AAward	+90K sh	—	—	90,000

Recent filings

Accepted (ET)
Apr 94
Kessler Paul D.0001491877-12-000022
SEC(opens sec.gov)
May 184
Kessler Paul D.0001455244-11-000025
SEC(opens sec.gov)
Apr 54
Kessler Paul D.0001455244-11-000015
SEC(opens sec.gov)
Mar 314
Kessler Paul D.0001455244-11-000013
SEC(opens sec.gov)
Jan 74
Kessler Paul D.0001455244-11-000002
SEC(opens sec.gov)
May 194
Kessler Paul D.0001491877-10-000002
SEC(opens sec.gov)

Companies

Vaxart, Inc.SVP Clinical, Med. & Reg.; CMOVXRT

Address

C/O NABI BIOPHARMACEUTICALS 12276 WILKINS AVE

ROCKVILLE, MD, 20852